Relay Therapeutics (RLAY) traded down -0.87 % during a 24 hours period ending at 04:30 PM Central Europe on Monday 26th. One Relay Therapeutics stock can currently be bought for about USD 18.32 on popular exchanges. Current supply of Relay Therapeutics stocks is 219.1 mn. Relay Therapeutics has a current market capitalization of USD 4 bn and approximately USD 34.5 mn worth of Relay Therapeutics was traded on exchanges in the last 24 hours. Since last month end, Relay Therapeutics has traded 2.54 % up. Simple moving average of last 200 days is at USD 14.72. The highest price of past 52 weeks was recorded at USD 21.27 on 08/19/2026. 52 weeks low was at USD 5.95 on 11/11/2025.
Here is how related stocks have performed in the past 24 hours:
Acushnet (GOLF) traded down -0.81 % and now trades at USD 82. Acushnet has a market capitalisation of USD 4.8 bn. Current price/earnings ratio for Acushnet is 22.3.
Rxo (RXO) traded down -0.59 % and now trades at USD 28.8. Current market capitalisation for Rxo is USD 4.7 bn.
Northwestern Energy (NWE) traded flat 0 % and now trades at USD 77.77. Northwestern Energy has a market capitalisation of USD 4.8 bn. Northwestern Energy has a current price to earnings ratio of 27.94. Northwestern Energy Group, listed on the ACE Market, completed its initial public offering in late October 2026. The company, which operates in the health‑food and personal‑care sectors, raised substantial capital by issuing new shares, a portion of which will support product development, research and expansion of its manufacturing capabilities. The IPO was well received, with significant oversubscription indicating investor confidence in the group’s strategy to broaden its product portfolio and strengthen in‑house research and development. The proceeds will also fund marketing efforts, working capital and the establishment of new sales facilities. Northwestern Energy Group has been focusing on reversing a recent decline in revenue by shifting toward higher‑margin products and expanding its direct‑sales network. The company’s forward outlook, supported by a projected recovery in profitability and growth in both domestic and international markets, has attracted analysts’ attention, with multiple firms maintaining a positive stance on the group’s valuation and future earnings potential.
Construction (ROAD) traded down -1.06 % and now trades at USD 83.45. Current market capitalisation for Construction is USD 4.7 bn. Construction has a current price to earnings ratio of 32.7.
Travere Therapeutics (TVTX) traded down -4.48 % and now trades at USD 49.75. Current market capitalisation for Travere Therapeutics is USD 4.7 bn.
About Relay Therapeutics
Relay Therapeutics, Inc. is a biotechnology company operating in the health care sector with its base in Cambridge, United States. The company specializes in developing drugs for the treatment of cancer. They serve their customers exclusively within the United States and can be accessed through their website at www.relaytx.com . Relay Therapeutics is listed on the Nasdaq stock exchange.
